# Hydroxocobalamin Injection: FDA shortage status

> FDA source status only. Nationwide status is not local pharmacy inventory. This page does not provide medical, treatment, substitution, or dosing advice.

- Derived status: current
- Source statuses: Current
- FDA package records: 2
- Latest FDA row update: 08/17/2026
- Retrieved: 2026-08-22T15:54:11+00:00

## FDA package and manufacturer records

- BTG International Inc. — Cyanokit, Injection, 5 g/250mL (NDC 50633-310-11) — FDA availability: Limited Availability — updated: 08/17/2026
- Teva Pharmaceuticals USA, Inc. — Hydroxocobalamin, Injection, 1000 MCG/ML, 30 ML Multi-Dose Vial (NDC 0591-2888-30) — FDA availability: Unavailable — updated: 08/04/2026

## Sources and formats

- [FDA openFDA source](https://api.fda.gov/drug/shortages.json)
- [Canonical HTML](https://citefacts.com/shortages/hydroxocobalamin-injection)
- [JSON record](https://citefacts.com/shortages/hydroxocobalamin-injection.json)